Journal Article

APC truncation and increased β-catenin levels in a human breast cancer cell line

Peter W. Schlosshauer, Stephen A. Brown, Katarina Eisinger, Qingyou Yan, Enrica R. Guglielminetti, Ramon Parsons, Lora Hedrick Ellenson and Jan Kitajewski

in Carcinogenesis

Volume 21, issue 7, pages 1453-1456
Published in print July 2000 | ISSN: 0143-3334
Published online July 2000 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/21.7.1453
APC truncation and increased β-catenin levels in a human breast cancer cell line

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

Mutations in the Adenomatous Polyposis Coli (APC) tumor suppressor gene or the β-catenin gene are present in most colon cancers and less frequently in other tumor types. In this study, we screened 24 human breast cancer cell lines and three immortalized human breast epithelial cell lines for alterations in β- and γ-catenin and APC by western blotting, protein truncation assay and DNA sequence analysis. In one cell line (DU 4475), an APC mutation was identified (E1577stop) that resulted in expression of truncated APC. This mutation was associated with elevated cytosolic β-catenin levels, probably due to loss of APC function, as in colon cancers. No mutations were found in exon 3 of the β- or γ-catenin genes. We conclude that APC mutations and β-catenin upregulation may occur with low frequency in human breast cancer cells.

Journal Article.  2901 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.